Frequently Asked Questions (Pharmacist)

How do I process a claim?

The Aimovig Ally™ Access Card has two offers within the program depending on whether the patient has eligible commercial coverage at the point of adjudication.

  1. If patient with commercial coverage is rejected or has a managed care restriction (i.e. Prior Authorization (PA), Step Edit or NDC Block), continue to process the card → Bridge Offer (i.e. Code 03): 1-Submit the claim to the primary Third-Party Payer first. 2-If you receive a rejection due to a Managed Care Restriction, continue processing the Aimovig Ally™ Access Card as a Secondary Payer with valid Other Coverage Code (OCC) of 03. *Note* that the patient is not responsible for any co-pay, and reimbursement will be received from Change Healthcare. Patient is limited to 12 total fills, not to exceed one fill per month. Offer is subject to a per fill cap of wholesale acquisition cost plus usual and customary pharmacy charges.

  2. If patient with commercial coverage is approved → Copay Offer (i.e. Code 08): Submit the claim to the primary Third-Party Payer first, then submit the balance due to Change Healthcare as a Secondary Payer with patient responsibility amount and a valid Other Coverage Code (OCC) of 8. The patient is responsible for the first $5 and reimbursement will be received from Change Healthcare up to the maximum limit for the program.

The Aimovig Ally™ Access Card is not valid for any patient uninsured or receiving prescription reimbursement under any federal-, state-, or government-funded healthcare program (e.g. Medicare).

**PLEASE NOTE: Every pharmacy has different systems and procedures. For any questions, the pharmacist or pharmacy tech can call the Change Healthcare Pharmacy Help Desk at 1-800-422-5604.


I’m getting a reject code when I run the card; it’s not working.

Ensure the patient’s primary insurance member ID is in the primary field, and access card ID is in secondary field;
this is the case whether patient is commercially insured and covered (OCC = 8) or commercially insured but not covered (OCC = 3).

If you get reject code = 70, 75, or 76, then patient should be in Bridge to Commercial Coverage offer (OCC = 3).

If the patient is receiving NDC 55513-841-02 (1 package of 2 syringes of 70 mg), that is quantity = 1.

For additional information, please call CHANGE HEALTHCARE at 800-422-5604.


How do I enroll a patient in the Aimovig Ally™ Access Card Program?
Patients must enroll themselves at www.aimovigaccesscard.com. They may do this on their desktop or mobile device. If the patient is unable to enroll online, they may call 833-Aimovig (833-246-6844). If a patient is eligible, they’ll instantly receive a card enrollment confirmation notice (the enrollment approval page that contains the patient and pharmacist instructions) which they can print and take to the pharmacy today with their prescription and insurance card. A copy of the Aimovig Ally™ Access Card will also be emailed to them upon successful enrollment.


For additional printable
instructions click here:

Bayer

Back


For more information about Aimovig® please visit: aimovig.com  | Privacy Policy  | Terms of Use

For more information about Aimovig please visit:   aimovig.com  | Privacy Policy  | Terms of Use

+

Important Safety Information

Who should not use Aimovig®?

Do not use Aimovig® if you are allergic to erenumab-aooe or any ingredients in Aimovig®.

Before starting Aimovig®, tell your healthcare provider (HCP) about all your medical conditions, including if you are allergic to rubber or latex, pregnant or plan to become pregnant, breastfeeding or plan to breastfeed.

Tell your HCP about all the medicines you take, including any prescription and over-the-counter medicines, vitamins, or herbal supplements.

What are possible side effects of Aimovig®?

Aimovig® may cause serious side effects, including:

  • Allergic reactions. Allergic reactions, including rash or swelling can happen after receiving Aimovig®. This can happen within hours to days after using Aimovig®. Call your HCP or get emergency medical help right away if you have any of the following symptoms of an allergic reaction: swelling of the face, mouth, tongue or throat, or trouble breathing.
  • Constipation with serious complications. Severe constipation can happen after receiving Aimovig®. In some cases people have been hospitalized or needed surgery. Contact your HCP if you have severe constipation.

The most common side effects of Aimovig® are pain, redness, or swelling at the injection site and constipation.

These are not all of the possible side effects of Aimovig®. Call your HCP for medical advice about side effects.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch, or call 1-800-FDA-1088.

Click here for Full Prescribing Information and Patient Product Information.

Approved Use

Aimovig® (erenumab-aooe) is a prescription medicine used for the preventive treatment of migraine in adults.

  

© 2019 Amgen Inc. All rights reserved.

Amgen Inc.
One Amgen Center Drive, Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080                                                   




© 2019 Amgen Inc. All rights reserved.

Amgen Inc. One Amgen Center Drive,Thousand Oaks, CA 91320-1799

Novartis Pharmaceuticals Corp.
One Health Plaza, East Hanover, NJ 07936-1080